A randomised dose ranging study of recombinant tissue plasminogen activator in acute myocardial infarction

To assess the thrombolytic efficacy and the effect on the systemic fibrinolytic system of recombinant tissue plasminogen activator doses of 20 mg, 50 mg, and 100 mg were compared in a randomised study. Tissue plasminogen activator was infused intravenously over 90 minutes in 50 consecutive patients...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: McNeill, A J, Shannon, J S, Cunningham, S R, Flannery, D J, Campbell, N P S, Khan, M M, Patterson, G C, Webb, S W, Adgey, A A J
Médium: Artigo
Jazyk:Inglês
Vydáno: 1988
Témata:
Papers and Short Reports
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2546238/
https://ncbi.nlm.nih.gov/pubmed/3136831
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky